In our previous work, we demonstrated that NVC can document NVC before and after erythropoietin (Epo) administration in neonates with moderate and severe HIE, and NVC was unchanged following Epo treatment, mirroring the lack of clinical efficacy at 2 years.39 This evidence concerns the gene EPO and perinatal asphyxia.